These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8066100)

  • 21. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
    Francini-Pesenti F; Beltramolli D; Dall'acqua S; Brocadello F
    Phytother Res; 2008 Mar; 22(3):318-22. PubMed ID: 18167048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.
    Greyling A; De Witt C; Oosthuizen W; Jerling JC
    Br J Nutr; 2006 May; 95(5):968-75. PubMed ID: 16611388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
    Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
    Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
    Prat H; Román O; Pino E
    Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ezetimibe-policosanol combination has the potential to be an OTC agent that could dramatically lower LDL cholesterol without side effects.
    McCarty MF
    Med Hypotheses; 2005; 64(3):636-45. PubMed ID: 15617880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of policosanol on atherosclerotic plaque on aortas in monkeys.
    Noa M; Mas R
    Arch Med Res; 2005; 36(5):441-7. PubMed ID: 16099319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological Interaction Between Policosanol and Nitroprusside in Rats.
    Arruzazabala ML; Carbajal D; Más R; Valdés S; Molina V
    J Med Food; 2001; 4(2):67-70. PubMed ID: 12639414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of policosanol on carbon tetrachloride-induced acute liver damage in Sprague-Dawley rats.
    Noa M; Mendoza S; Más R; Mendoza N
    Drugs R D; 2003; 4(1):29-35. PubMed ID: 12568632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Policosanol: a new treatment for cardiovascular disease?
    Janikula M
    Altern Med Rev; 2002 Jun; 7(3):203-17. PubMed ID: 12126462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Policosanol as a new inhibitor candidate for vascular calcification in diabetic hyperlipidemic rats.
    Elseweidy MM; Zein N; Aldhamy SE; Elsawy MM; Saeid SA
    Exp Biol Med (Maywood); 2016 Nov; 241(17):1943-1949. PubMed ID: 27460718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmacological surveillance study of the tolerability of policosanol in the elderly population.
    Fernández S; Más R; Gamez R; Diaz A; Fernández J; Deibis Orta S; Illnait J; Castańo G; Mendoza S; Valdés F; Alvarez E
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):219-29. PubMed ID: 15903280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of policosanol on circulating endothelial cells in experimental models in Sprague-Dawley rats and in rabbits.
    Noa M; Más R; Mesa R
    J Pharm Pharmacol; 1997 Oct; 49(10):999-1002. PubMed ID: 9364410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of policosanol on lipofundin-induced atherosclerotic lesions in rats.
    Noa M; Más R; de la Rosa MC; Magraner J
    J Pharm Pharmacol; 1995 Apr; 47(4):289-91. PubMed ID: 7791025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Policosanol prevents bone loss in ovariectomized rats.
    Noa M; Más R; Mendoza S; Gámez R; Mendoza N; González J
    Drugs Exp Clin Res; 2004; 30(3):117-23. PubMed ID: 15366788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
    Gong J; Qin X; Yuan F; Hu M; Chen G; Fang K; Wang D; Jiang S; Li J; Zhao Y; Huang Z; Dong H; Lu F
    Mol Nutr Food Res; 2018 Jan; 62(1):. PubMed ID: 28730734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
    Castaño G; Más R; Fernández JC; Illnait J; Fernández L; Alvarez E
    J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):M186-92. PubMed ID: 11253161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites.
    Molina V; Arruzazabala ML; Carbajal D; Más R
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jul; 67(1):19-24. PubMed ID: 12213431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of policosanol on foam-cell formation in carrageenan-induced granulomas in rats.
    Noa M; de la Rosa MC; Más R
    J Pharm Pharmacol; 1996 Mar; 48(3):306-9. PubMed ID: 8737059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.